Clarifying the causal relevance of these signatures will require longitudinal human studies and targeted epigenetic manipulation in defined neural circuits
Analytical Documentation Search available certificates by product, strength, lot number, testing date, and test type
In sum, current evidence positions GLP-1 RAs as a potential cardioprotective strategy in HF, with HF with preserved ejection fraction emerging as the clinically most relevant phenotype for the drug class, especially when occurring in people with obesity with and without diabetes
Acknowledgements The participants of the GSH-MAP Study Group at Nantes CHU are acknowledged for their help with data monitoring and clinical statistical analysis: Soizic Boinet, Aziz Ouach, Christopher Peltreau, and Paul-Antoine Lagrange
Peptide therapy extends beyond shedding pounds
People with active tumors or histories of hormone-sensitive cancers are typically advised against any growth hormone-related therapy, including sermorelin